$ISIS Recent News S&P confirms uptrend, pulls in from

New Post Public Reply Private Reply Replies (0) Message Board

Jan 6, 2015 at 10:00 AM

$ISIS Recent News

S&P confirms uptrend, pulls in from record high 10:59 a.m. Nov. 19, 2014 - Michael Ashbaugh
Strong bull trend absorbs Fed-induced whipsaw 9:59 a.m. Oct. 30, 2014 - Michael Ashbaugh
This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
A lesson in buying low in a high group 11:01 p.m. Sept. 1, 2014 - Michael Kahn
5 companies that will benefit from ALS awareness 6:58 a.m. Aug. 22, 2014 - Jennifer Booton
Investors blow on the dice as Iraq and the Fed shake up markets 8:09 a.m. June 16, 2014 - Shawn Langlois
S&P, Dow pull in from latest record highs 10:10 a.m. June 2, 2014 - Michael Ashbaugh
Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt

Isis Pharmaceuticals (ISIS) in Focus: Stock Soars 10.7% - Tale of the Tape 39 min ago - Zacks.com
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015 8:30 a.m. Today - TheStreet.com
Jim Cramer's Top Stock Picks: INTC UNH HD MSFT CSCO ISIS 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: My 10 Ways to Make Your 2014 Gains Continue in 2015 8:27 p.m. Jan. 5, 2015 - TheStreet.com
Hot Biotech Stocks: Isis, Kite Jump On Big Deals 5:20 p.m. Jan. 5, 2015 - Investors Business Daily
3 Drugs Stocks Nudging The Industry Higher 1:08 p.m. Jan. 5, 2015 - TheStreet.com
Isis Pharma To Develop GI Drugs With J&J 12:17 p.m. Jan. 5, 2015 - Investors Business Daily
Jim Cramer: Isis Pharmaceuticals Gets a 'Gigantic' Boost With J&J Deal 11:53 a.m. Jan. 5, 2015 - TheStreet.com
Why Boston Scientific, ISIS Pharmecuticals, and RCS Capital are 3 of Today’s Best Stocks 10:55 a.m. Jan. 5, 2015 - InvestorPlace.com
Today's Market: Biotech Names Rallying, Retail Buyout Candidates 10:08 a.m. Jan. 5, 2015 - Seeking Alpha
Isis Pharmaceuticals (ISIS) Off To A Strong Start In Pre-Market Activity 7:59 a.m. Jan. 5, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ISIS BSX MNKD BLUE 7:00 a.m. Jan. 5, 2015 - InvestorPlace.com
Will Biotech Fire On All Cylinders In 2015? 4:15 p.m. Dec. 30, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS NBIX CLDX EXAS 6:15 a.m. Dec. 26, 2014 - InvestorPlace.com
Isis Pharmaceuticals (ISIS) Showing Signs Of A Dead Cat Bounce Today 9:56 a.m. Dec. 24, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ACHN BLUE ISIS HALO 7:00 a.m. Dec. 24, 2014 - InvestorPlace.com
Isis Pharmaceuticals (ISIS) Stock: Weak On High Volume Today 10:04 a.m. Dec. 23, 2014 - TheStreet.com
Cramer: ‘Downside’ to Biotech as ImmunoGen Stock Cut in Half 10:46 a.m. Dec. 19, 2014 - TheStreet.com
Why Isis Pharmaceuticals (ISIS) Stock Might be a Great Pick - Tale of the Tape 9:00 a.m. Dec. 19, 2014 - Zacks.com
Hottest Healthcare Stocks Now – PBYI HALO ISIS PRGO 6:30 a.m. Dec. 19, 2014 - InvestorPlace.com

Critical Alerts For JetBlue, Isis Pharmaceuticals, Gold Fields, 58.com and 51job Released By InvestorsObserver 29 min ago - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Today - PR Newswire - PRF
Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics 7:00 a.m. Today - PR Newswire - PRF
Isis Pharmaceuticals Appoints Sarah Boyce As Chief Business Officer 6:00 p.m. Jan. 5, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Announces Collaboration With Janssen to Discover and Develop RNA-Targeted Therapeutics for Autoimmune Diseases in the GI Tract 7:00 a.m. Jan. 5, 2015 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference 11:00 a.m. Jan. 2, 2015 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 1/2 Study of ISIS-DMPK Rx in Patients With Myotonic Dystrophy Type 1 7:00 a.m. Dec. 16, 2014 - PR Newswire - PRF
Critical Alerts For Mobileye NV, bluebird bio Inc., Isis Pharmaceuticals, Castlight Health and ConocoPhillips Released By InvestorsObserver 9:31 a.m. Dec. 9, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS-FXI Rx for the Prevention of Venous Thrombosis in Patients Undergoing Total Knee Replacement Surgery 2:05 p.m. Dec. 7, 2014 - PR Newswire - PRF
Isis Pharmaceuticals' CEO, Dr. Stanley Crooke, Receives Prestigious SCRIP Lifetime Achievement Award 7:00 a.m. Dec. 5, 2014 - PR Newswire - PRF
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
ISIS-APOCIII Rx Phase 2 Study in Patients With Familial Chylomicronemia Published in the New England Journal of Medicine 5:05 p.m. Dec. 3, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Children With Spinal Muscular Atrophy 7:00 a.m. Nov. 25, 2014 - PR Newswire - PRF
ISIS-STAT3 Rx and ISIS-AR Rx Data Presented by AstraZeneca at European Cancer Symposium 4:47 p.m. Nov. 20, 2014 - PR Newswire - PRF
Genzyme and Isis Present KYNAMRO® Clinical Data at the American Heart Association 3:45 p.m. Nov. 18, 2014 - BusinessWire - BZX
Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 7:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Cure SMA Presents Isis Pharmaceuticals with SMA Breakthrough Award 12:04 p.m. Nov. 17, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at Upcoming Investor Conferences 7:00 a.m. Nov. 14, 2014 - PR Newswire - PRF
AstraZeneca and Isis Pharmaceuticals to Co-Develop Targeted Oligonucleotide Delivery Methods 3:01 a.m. Nov. 13, 2014 - PR Newswire - PRF
Critical Alerts For Twitter, Isis Pharmaceuticals, TrueCar and Myriad Genetics Released By InvestorsObserver 9:31 a.m. Nov. 12, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces $100K+ Losses in New Investor Lawsuit

When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...

Testing Grounds: Navigating PRN Test Insights

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Rho Adds Credit Card Payments to Invoices

Rho's New Game: Credit Card Payments on Invoices Ah, the wonderful world where your invoices can finally ride the plastic wave! Rho, that scrappy finance platform everyone's been chattering about, just rolled out a card payment feature. Yep, from credit cards to Google Pay, they’re letting businesses skip the usual financial hurdles and get their dough directly from...

Tuya Presents Doova: A Senior-Friendly AI Robot

IFA Unveils a Game-Changer for Senior Living Imagine having a helper at home that not only looks out for your safety but also keeps you company. That's exactly what Tuya Smart's new AI creation, Doova, is set to do. Unveiled at the IFA 2026, Doova isn't just another gadget—it’s a big leap for folks choosing to live out their golden years independently. Navigating...

Bamboo Unveils Tailored Home Insurance for Texans

Adapt or Get Left Behind: The Texas Insurance Scene In a world where costs are ballooning and the pressure on the wallet grows heavier, here comes Bamboo Insurance swinging into Texas like a hopeful knight. This plucky insurer is rolling out the Texas Essential Homeowner Program, a highly adaptable, admitted policy that promises to put some power back into the hands of...

2026 AI Talent Study Reveals Growth and Gaps

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

AARP New York Promotes Affordable 'Staycation' Experiences

Exploring New York Without Breaking the Bank Tough times call for creative solutions, and AARP New York is on the ball. With travel costs soaring and many older New Yorkers scrimping to make ends meet, the 'Staycation' campaign steps in with an offer too good to pass up: uncovering the gems of New York right under our noses without shelling out hefty sums. The plan? Turn...

S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Potomac Edison Eyes Rate Hike for System Overhaul

FirstEnergy's Potomac Edison Pushes for Rate Adjustment The walls are closing in on the energy sector, and Potomac Edison is seizing the moment. With their proposed $52.8 million rate adjustment, they're not only aiming to keep the lights on but to power up their entire infrastructure game. It's a gutsy move, particularly in volatile times. The Price Tag: Weighing Costs...

Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...